Lipoprotein(a): novel target and emergence of novel therapies to lower cardiovascular disease risk
about
Lipoprotein (a) as a cause of cardiovascular disease: insights from epidemiology, genetics, and biologyComprehensive metabolomics identified lipid peroxidation as a prominent feature in human plasma of patients with coronary heart diseasesAnti-sense oligonucleotide therapies for the treatment of hyperlipidaemia.Emerging Therapeutic Options for Lowering of Lipoprotein(a): Implications for Prevention of Cardiovascular Disease.Lipoprotein(a) in clinical practice: New perspectives from basic and translational science.Dyslipidaemia in the elderly: to treat or not to treat?Cardiovascular Outcomes of PCSK9 Inhibitors: With Special Emphasis on Its Effect beyond LDL-Cholesterol Lowering.
P2860
Q30242031-17C5D465-BBE6-4839-8473-6B2A116B2BD3Q33633974-08A849D5-2135-416E-99E4-9F090826388DQ38850010-CE143D57-5931-4B8E-80B2-5F4C6DFA0831Q38985774-4E3C1E5E-0C9D-4D5C-9351-04A774FA705FQ47274864-4693C9F4-69C8-4C61-A140-570CA9AD728EQ50180407-CB1F23DE-A528-4F93-B283-6996C7A551D0Q54971522-181A6F6C-ADC6-479A-99FE-F4A346E2D6DB
P2860
Lipoprotein(a): novel target and emergence of novel therapies to lower cardiovascular disease risk
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 25 January 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Lipoprotein(a): novel target a ...... er cardiovascular disease risk
@en
type
label
Lipoprotein(a): novel target a ...... er cardiovascular disease risk
@en
prefLabel
Lipoprotein(a): novel target a ...... er cardiovascular disease risk
@en
P2860
P1476
Lipoprotein(a): novel target a ...... er cardiovascular disease risk
@en
P2860
P304
P356
10.1097/MED.0000000000000237
P577
2016-01-25T00:00:00Z